The relationship between cancer associated fibroblasts biomarkers and prognosis of breast cancer: a systematic review and meta-analysis

Background To elucidate the relationship between cancer-associated fibroblast (CAFs) biomarkers and the prognosis of breast cancer patients for individualized CAFs-targeting treatment. Methodology PubMed, Web of Science, Cochrane, and Embase databases were searched for CAFs-related studies of breast...

Full description

Bibliographic Details
Main Authors: Meimei Cui, Hao Dong, Wanli Duan, Xuejie Wang, Yongping Liu, Lihong Shi, Baogang Zhang
Format: Article
Language:English
Published: PeerJ Inc. 2024-02-01
Series:PeerJ
Subjects:
Online Access:https://peerj.com/articles/16958.pdf
_version_ 1797295339690000384
author Meimei Cui
Hao Dong
Wanli Duan
Xuejie Wang
Yongping Liu
Lihong Shi
Baogang Zhang
author_facet Meimei Cui
Hao Dong
Wanli Duan
Xuejie Wang
Yongping Liu
Lihong Shi
Baogang Zhang
author_sort Meimei Cui
collection DOAJ
description Background To elucidate the relationship between cancer-associated fibroblast (CAFs) biomarkers and the prognosis of breast cancer patients for individualized CAFs-targeting treatment. Methodology PubMed, Web of Science, Cochrane, and Embase databases were searched for CAFs-related studies of breast cancer patients from their inception to September, 2023. Meta-analysis was performed using R 4.2.2 software. Sensitivity analyses were performed to explore the sources of heterogeneity. Funnel plot and Egger’s test were used to assess the publication bias. Results Twenty-seven studies including 6,830 patients were selected. Univariate analysis showed that high expression of platelet-derived growth factor receptor-β (PDGFR-β) (P = 0.0055), tissue inhibitor of metalloproteinase-2 (TIMP-2) (P < 0.0001), matrix metalloproteinase (MMP) 9 (P < 0.0001), MMP 11 (P < 0.0001) and MMP 13 (P = 0.0009) in CAFs were correlated with reduced recurrence-free survival (RFS)/disease-free survival (DFS)/metastasis-free survival (MFS)/event-free survival (EFS) respectively. Multivariate analysis showed that high expression of α-smooth muscle actin (α-SMA) (P = 0.0002), podoplanin (PDPN) (P = 0.0008), and PDGFR-β (P = 0.0470) in CAFs was associated with reduced RFS/DFS/MFS/EFS respectively. Furthermore, PDPN and PDGFR-β expression in CAFs of poorly differentiated breast cancer patients were higher than that of patients with relatively better differentiated breast cancer. In addition, there is a positive correlation between the expression of PDPN and human epidermal growth factor receptor-2 (HER-2). Conclusions The high expression of α-SMA, PDPN, PDGFR-β in CAFs leads to worse clinical outcomes in breast cancer, indicating their roles as prognostic biomarkers and potential therapeutic targets.
first_indexed 2024-03-07T21:46:15Z
format Article
id doaj.art-500813f580e54290b011d4ce213b2ec7
institution Directory Open Access Journal
issn 2167-8359
language English
last_indexed 2024-03-07T21:46:15Z
publishDate 2024-02-01
publisher PeerJ Inc.
record_format Article
series PeerJ
spelling doaj.art-500813f580e54290b011d4ce213b2ec72024-02-25T15:05:19ZengPeerJ Inc.PeerJ2167-83592024-02-0112e1695810.7717/peerj.16958The relationship between cancer associated fibroblasts biomarkers and prognosis of breast cancer: a systematic review and meta-analysisMeimei Cui0Hao Dong1Wanli Duan2Xuejie Wang3Yongping Liu4Lihong Shi5Baogang Zhang6Department of Pathology, School of Basic Medical Sciences, Shandong Second Medical University, Weifang, Shandong, ChinaDepartment of Pathology, School of Basic Medical Sciences, Shandong Second Medical University, Weifang, Shandong, ChinaDepartment of Pathology, School of Basic Medical Sciences, Shandong Second Medical University, Weifang, Shandong, ChinaDepartment of Pathology, School of Basic Medical Sciences, Shandong Second Medical University, Weifang, Shandong, ChinaDepartment of Pathology, School of Basic Medical Sciences, Shandong Second Medical University, Weifang, Shandong, ChinaSchool of Rehabilitation Medicine, Shandong Second Medical University, Weifang, Shandong, ChinaDepartment of Pathology, School of Basic Medical Sciences, Shandong Second Medical University, Weifang, Shandong, ChinaBackground To elucidate the relationship between cancer-associated fibroblast (CAFs) biomarkers and the prognosis of breast cancer patients for individualized CAFs-targeting treatment. Methodology PubMed, Web of Science, Cochrane, and Embase databases were searched for CAFs-related studies of breast cancer patients from their inception to September, 2023. Meta-analysis was performed using R 4.2.2 software. Sensitivity analyses were performed to explore the sources of heterogeneity. Funnel plot and Egger’s test were used to assess the publication bias. Results Twenty-seven studies including 6,830 patients were selected. Univariate analysis showed that high expression of platelet-derived growth factor receptor-β (PDGFR-β) (P = 0.0055), tissue inhibitor of metalloproteinase-2 (TIMP-2) (P < 0.0001), matrix metalloproteinase (MMP) 9 (P < 0.0001), MMP 11 (P < 0.0001) and MMP 13 (P = 0.0009) in CAFs were correlated with reduced recurrence-free survival (RFS)/disease-free survival (DFS)/metastasis-free survival (MFS)/event-free survival (EFS) respectively. Multivariate analysis showed that high expression of α-smooth muscle actin (α-SMA) (P = 0.0002), podoplanin (PDPN) (P = 0.0008), and PDGFR-β (P = 0.0470) in CAFs was associated with reduced RFS/DFS/MFS/EFS respectively. Furthermore, PDPN and PDGFR-β expression in CAFs of poorly differentiated breast cancer patients were higher than that of patients with relatively better differentiated breast cancer. In addition, there is a positive correlation between the expression of PDPN and human epidermal growth factor receptor-2 (HER-2). Conclusions The high expression of α-SMA, PDPN, PDGFR-β in CAFs leads to worse clinical outcomes in breast cancer, indicating their roles as prognostic biomarkers and potential therapeutic targets.https://peerj.com/articles/16958.pdfBreast cancerCancer associated fibroblastsMeta-analysisPrognostic biomarkers
spellingShingle Meimei Cui
Hao Dong
Wanli Duan
Xuejie Wang
Yongping Liu
Lihong Shi
Baogang Zhang
The relationship between cancer associated fibroblasts biomarkers and prognosis of breast cancer: a systematic review and meta-analysis
PeerJ
Breast cancer
Cancer associated fibroblasts
Meta-analysis
Prognostic biomarkers
title The relationship between cancer associated fibroblasts biomarkers and prognosis of breast cancer: a systematic review and meta-analysis
title_full The relationship between cancer associated fibroblasts biomarkers and prognosis of breast cancer: a systematic review and meta-analysis
title_fullStr The relationship between cancer associated fibroblasts biomarkers and prognosis of breast cancer: a systematic review and meta-analysis
title_full_unstemmed The relationship between cancer associated fibroblasts biomarkers and prognosis of breast cancer: a systematic review and meta-analysis
title_short The relationship between cancer associated fibroblasts biomarkers and prognosis of breast cancer: a systematic review and meta-analysis
title_sort relationship between cancer associated fibroblasts biomarkers and prognosis of breast cancer a systematic review and meta analysis
topic Breast cancer
Cancer associated fibroblasts
Meta-analysis
Prognostic biomarkers
url https://peerj.com/articles/16958.pdf
work_keys_str_mv AT meimeicui therelationshipbetweencancerassociatedfibroblastsbiomarkersandprognosisofbreastcancerasystematicreviewandmetaanalysis
AT haodong therelationshipbetweencancerassociatedfibroblastsbiomarkersandprognosisofbreastcancerasystematicreviewandmetaanalysis
AT wanliduan therelationshipbetweencancerassociatedfibroblastsbiomarkersandprognosisofbreastcancerasystematicreviewandmetaanalysis
AT xuejiewang therelationshipbetweencancerassociatedfibroblastsbiomarkersandprognosisofbreastcancerasystematicreviewandmetaanalysis
AT yongpingliu therelationshipbetweencancerassociatedfibroblastsbiomarkersandprognosisofbreastcancerasystematicreviewandmetaanalysis
AT lihongshi therelationshipbetweencancerassociatedfibroblastsbiomarkersandprognosisofbreastcancerasystematicreviewandmetaanalysis
AT baogangzhang therelationshipbetweencancerassociatedfibroblastsbiomarkersandprognosisofbreastcancerasystematicreviewandmetaanalysis
AT meimeicui relationshipbetweencancerassociatedfibroblastsbiomarkersandprognosisofbreastcancerasystematicreviewandmetaanalysis
AT haodong relationshipbetweencancerassociatedfibroblastsbiomarkersandprognosisofbreastcancerasystematicreviewandmetaanalysis
AT wanliduan relationshipbetweencancerassociatedfibroblastsbiomarkersandprognosisofbreastcancerasystematicreviewandmetaanalysis
AT xuejiewang relationshipbetweencancerassociatedfibroblastsbiomarkersandprognosisofbreastcancerasystematicreviewandmetaanalysis
AT yongpingliu relationshipbetweencancerassociatedfibroblastsbiomarkersandprognosisofbreastcancerasystematicreviewandmetaanalysis
AT lihongshi relationshipbetweencancerassociatedfibroblastsbiomarkersandprognosisofbreastcancerasystematicreviewandmetaanalysis
AT baogangzhang relationshipbetweencancerassociatedfibroblastsbiomarkersandprognosisofbreastcancerasystematicreviewandmetaanalysis